Huang, H., Zhang, X., Xie, Y., Zhao, Y., Zhang, Y., Fan, X. (2025). Neoadjuvant treatment with disitamab vedotin monotherapy in patients with HER2-overexpressing muscle invasive bladder cancer (MIBC): An open-label, single-arm, phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16584